Data from A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/930F2AB2.svg?ark=w1%2F20261004%2F930F2AB2&value=id)](https://nobleid.org/work/w1/20261004/930F2AB2)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →